FR2819255B1 - CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT - Google Patents
CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENTInfo
- Publication number
- FR2819255B1 FR2819255B1 FR0100205A FR0100205A FR2819255B1 FR 2819255 B1 FR2819255 B1 FR 2819255B1 FR 0100205 A FR0100205 A FR 0100205A FR 0100205 A FR0100205 A FR 0100205A FR 2819255 B1 FR2819255 B1 FR 2819255B1
- Authority
- FR
- France
- Prior art keywords
- application
- chemical derivatives
- antitelomerase
- agent
- antitelomerase agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0100205A FR2819255B1 (en) | 2001-01-09 | 2001-01-09 | CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT |
EP02710956A EP1351957A1 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
JP2002556184A JP2004520350A (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as antitelomerase agents |
CA002433723A CA2433723A1 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
MXPA03005975A MXPA03005975A (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent. |
IL15679402A IL156794A0 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
PCT/FR2002/000057 WO2002055515A1 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
US10/040,370 US6858608B2 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their application as antitelomerase agents |
AU2002229859A AU2002229859B2 (en) | 2001-01-09 | 2002-01-09 | Chemical derivatives and their use as anti-telomerase agent |
US10/954,808 US7179816B2 (en) | 2001-01-09 | 2004-09-30 | Chemical derivatives and their application as antitelomerase agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0100205A FR2819255B1 (en) | 2001-01-09 | 2001-01-09 | CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2819255A1 FR2819255A1 (en) | 2002-07-12 |
FR2819255B1 true FR2819255B1 (en) | 2003-02-28 |
Family
ID=8858610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0100205A Expired - Fee Related FR2819255B1 (en) | 2001-01-09 | 2001-01-09 | CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1351957A1 (en) |
JP (1) | JP2004520350A (en) |
AU (1) | AU2002229859B2 (en) |
CA (1) | CA2433723A1 (en) |
FR (1) | FR2819255B1 (en) |
IL (1) | IL156794A0 (en) |
MX (1) | MXPA03005975A (en) |
WO (1) | WO2002055515A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887873B2 (en) | 2001-03-23 | 2005-05-03 | Aventis Pharma S.A. | Triazine derivatives and their application as antitelomerase agents |
US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
FR2850970B1 (en) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | CHEMICAL DERIVATIVES BINDING VERY SPECIFIC TO G-QUADRUPLEX DNA STRUCTURES AND THEIR APPLICATION AS A SPECIFIC ANTICANCER AGENT |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
US5767278A (en) * | 1995-10-06 | 1998-06-16 | Geron Corporation | Telomerase inhibitors |
JPH1160573A (en) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | Triazine derivative and telomerase inhibitor |
-
2001
- 2001-01-09 FR FR0100205A patent/FR2819255B1/en not_active Expired - Fee Related
-
2002
- 2002-01-09 MX MXPA03005975A patent/MXPA03005975A/en not_active Application Discontinuation
- 2002-01-09 CA CA002433723A patent/CA2433723A1/en not_active Abandoned
- 2002-01-09 JP JP2002556184A patent/JP2004520350A/en not_active Abandoned
- 2002-01-09 AU AU2002229859A patent/AU2002229859B2/en not_active Expired - Fee Related
- 2002-01-09 IL IL15679402A patent/IL156794A0/en unknown
- 2002-01-09 EP EP02710956A patent/EP1351957A1/en not_active Withdrawn
- 2002-01-09 WO PCT/FR2002/000057 patent/WO2002055515A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1351957A1 (en) | 2003-10-15 |
WO2002055515A1 (en) | 2002-07-18 |
IL156794A0 (en) | 2004-02-08 |
AU2002229859B2 (en) | 2008-03-13 |
CA2433723A1 (en) | 2002-07-18 |
FR2819255A1 (en) | 2002-07-12 |
MXPA03005975A (en) | 2005-02-14 |
JP2004520350A (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR20C1039I2 (en) | DERIVATIVES OF UK-2A | |
DE60215046D1 (en) | BREAKER AND APPLICATION PROCESS | |
IS6858A (en) | Trisol pyridine as an anti-inflammatory agent | |
ID30393A (en) | TIENOPIRIMIDINA COMPOUNDS, MAKING AND USE OF IT | |
MA27001A1 (en) | NOVEL SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS PHOSPHO-DIESTERASE-7 INHIBITORS | |
DE60204857D1 (en) | Atomizer | |
NO20034490D0 (en) | Method of composition of absorbent article for personal care | |
ATE555761T1 (en) | ABSORBENT ARTICLE | |
DE60209850D1 (en) | Absorbent article | |
DE60214783D1 (en) | Absorbent article | |
FR2830516B1 (en) | SUSPENSION OF TURBOJET | |
BR0201972B1 (en) | amount of suspension. | |
DE60225452D1 (en) | RECESSIBLE ABSORBENT ARTICLE | |
PT1250321E (en) | COMPOSITION OF GLIBURIDA | |
ITMI20021834A1 (en) | SUSPENSION OF EQUIPMENT | |
DE60208700D1 (en) | SCHÄLGERÄT AND ASSOCIATED PROCEDURES | |
FI20011300A0 (en) | Sprinkler | |
NO20041968L (en) | Use of cystationin | |
BR0209263B1 (en) | coating compositions comprising high area t carbon products | |
FI20010075A (en) | Functional product and method | |
DE60233109D1 (en) | RADIDENTIFICATOR LOCATION PROCESS | |
NO20035605D0 (en) | Pediatric formulation of gatifloxacin | |
LU90483B1 (en) | New compositions of parox-tine m-thanesulfonate | |
FR2819255B1 (en) | CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENT | |
DE60225446D1 (en) | FLAME-PROTECTED COMPOSITION AND ARTICLES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20091030 |